Updated

Researchers have identified a gut bacterial compound called ImP that is associated with increased Alzheimer's disease risk, harmful brain protein buildup, and faster cognitive decline. The study strengthens the growing body of evidence connecting gut microbiome composition to brain health. Scientists suggest that reducing ImP levels in the blood could one day serve as a strategy to slow or prevent dementia, though further research is needed before any clinical application.